Background: Extraintestinal manifestations (EIMs) in pediatric patients with inflammatory bowel disease (IBD) are poorly characterized. We examined the prevalence of EIMs at diagnosis, subsequent incidence, and risk factors for EIMs. ## Methods: Data for 1649 patients from the PediIBD Consortium
Treatment of extraintestinal manifestations of inflammatory bowel disease
β Scribed by Dr. Richard J. Grand
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 109 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The inflammatory bowel diseases (IBD), notably Crohn's disease (CD) and ulcerative colitis (UC), are systemic inflammatory diseases primarily involving the gastrointestinal tract. Twenty percent to 40% of patients with IBD develop extraintestinal inflammation and symptoms, known as extraintestinal m
## Background: The aim of this study was to evaluate the prevalence and features of the major cutaneous manifestations (erythema nodosum [en] and pyoderma gangrenosum [pg]) and to determine the associations between cutaneous manifestations and other extraintestinal manifestations in patients with i
Renal manifestations and complications are not rare in patients with inflammatory bowel disease (IBD) and may present as nephrolithiasis, amyloidosis, tubulointerstitial nephritis, and glomerulonephritis. Symptoms of renal impairment are not always specific and since the underlying bowel disease is
## Background: Ophthalmologic diseases in patients with inflammatory bowel disease (ibd) have been reported with varying frequency, mostly from tertiary referral centers. the aim was to describe the spectrum of ophthalmologic conditions in patients with ibd in a community setting and to compare it